The News Review:

- Illumina to Present at the Goldman Sachs 29th Annual Global Healthcare…
- Highlights of the north
- Heart Failure Patients ften verestimate Their wn Life Expectancy

Illumina to Present at the Goldman Sachs 29th Annual Global Healthcare…
Earthtimes – Jun 4, 2008
com) is a leading developer manufacturer and marketer of next-generation life-science tools and integrated systems for the large-scale analysis of genetic variation and biological function. Using our proprietary technologies we provide a comprehensive line of products and services that currently serve the sequencing genotyping and gene expression markets and we expect to enter the market for molecular diagnostics. ur customers include leading genomic research centers pharmaceutical companies academic institutions clinical research organizations and biotechnology companies. ur tools provide researchers around the world with the performance throughput cost effectiveness and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function which will enhance drug discovery and clinical research allow diseases to be detected earlier and permit better choices of drugs for individual patients. “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: this release may contain forward-looking statements that involve risks and uncertainties. Among the important factors that could cause actual results to differ materially from those in any forward-looking statements are Illumina’s ability (i) to integrate effectively our recent acquisition of Solexa Inc.

Highlights of the north
New Scientist – New Scientist (subscription) – Jun 4, 2008
Nowadays Scotland is getting just as good at turning research into business as it is at doing the research in the first place. ne initiative has been particularly successful in translating research into remedy. The aptly named Translational Medicine Research Collaboration (TMRC) is a newly established network of clinical research centres involving the medical schools at Aberdeen Dundee Glasgow and Edinburgh universities a core research lab hosted by the University of Dundee US-based Wyeth Pharmaceuticals and the NHS. The collaboration aims to develop treatments and drugs by researching how to better diagnose and monitor disease. Looking for a job in science or technology? Take a look at the latest opportunities on.

Heart Failure Patients ften verestimate Their wn Life Expectancy
Science Daily – Science Daily (press release) – Jun 4, 2008
Dodson RN MSN; Christopher M. %u2019Connor MD; G. Michael Felker MD MHS. Discordance Between Patient-Predicted and Model-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure. JAMA 2008;299(21):2533-2542 [.